Failure of short-term hyperinsulinemia to affect testosterone production rates in healthy men

Metabolism: Clinical and Experimental

Volumn 47, Issue 1, 1998, Pages 119-120

  Vierhapper, H ^a   Nowotny, P ^a   Waldhausl W ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; TESTOSTERONE;

ADULT; ARTICLE; GAS CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; HYPERANDROGENISM; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; ISOTOPE LABELING; MALE; MASS SPECTROMETRY; NORMAL HUMAN; PRIORITY JOURNAL; STEROIDOGENESIS; TESTOSTERONE BLOOD LEVEL;

EID: 0031886130     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(98)90204-9     Document Type: Article

References (17)

1. Poretsky L: On the paradox of insulin-induced hyperandrogenism in insulin-resistant states. Endocr Rev 12:3-13, 1991
2. Poretsky L: Insulin resistance and hyperandrogenism: Update 1994. Endocr Rev 2:125-129, 1994
3. Nestler JE, McClanahan MA, Clore JN, et al: Insulin inhibits adrenal 17,20-lyase activity in man. J Clin Endocrinol Metab 74:362-367, 1992
4. Pasquali R, Casimirri F, de Iasio R, et al: Insulin regulates testosterone and sex hormone-binding globulin concentrations in adult normal weight and obese men. J Clin Endocrinol Metab 80:654-658, 1995
5. Moghetti P, Castello R, Negri C, et al: Insulin infusion amplifies 17a-hydroxycorticosteroid intermediates response to adrenocorticotropin in hyperandrogenic women: Apparent relative impairment of 17,20-lyase activity. J Clin Endocrinol Metab 81:881-886, 1996
6. 13C-labelled testosterone in man. J Steroid Biochem 29:105-109, 1988
7. 13C-labelled testosterone in humans. Steroids 55:177-180, 1990
8. Esteban NV, Loughlin T, Yergey AL, et al: Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry. J Clin Endocrinol Metab 71:39-45, 1991
9. Waldhäusl W, Kleinberger G, Korn A, et al: Severe hyperglycemia: Effects of rehydration and endocrine derangements and blood glucose concentrations. Diabetes 28:577-584, 1979
10. Wootton R, Ford GC, Cheng KN, et al Calculation of turnover rates in stable-isotope studies. Phys Med Biol 30:1143-1149, 1985
11. Polderman KH, Gooren LJ, Asscheman H, et al Induction of insulin resistance by androgens and estrogens. J Clin Endocrinol Metab 79:265-271, 1994
12. Velasquez EM, Mendoza S, Hamer T, et al: Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy. Metabolism 43:647-654, 1994
13. Crave J-C, Fimbel S, Lejeune H, et al Effect of diet and metformin administration on sex hormone-binding globulin, androgens, and insulin in hirsute and obese women. J Clin Endocrinol Metab 80:2057-2062, 1995
14. Nieschlag E: Circadian rhythm of plasma testosterone, in Aschoff J, Ceresa F, Halberg F (eds): Chronobiological Aspects of Endocrinology Stuttgart, Germany, Schattauer-Verlag, 1994, p 117
15. Bremner WJ, Vitiello MV, Prinz PN: Loss of circadian rhythmicity in blood testosterone levels with aging in normal men. J Clin Endocrinol Metab 56:1278-1281, 1983
16. Vierhapper H, Nowotny P, Waldhäusl W: Determination of testosterone production rates in men and women using stable isotope/ dilution and mass spectrometry. J Clin Endocrinol Metab 82:1492-1496, 1997
17. Nestler JE, Jakubowicz DJ: Decreases in ovarian cytochrome P450c17α activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 335:617-623, 1996